Health ❯ Pharmaceuticals

Medications

GLP-1 Drugs GLP-1 Diabetes Treatment Ozempic Paracetamol Semaglutide Weight Loss Antibiotics Side Effects Chemotherapy Drugs Active Ingredients GLP-1 Receptor Agonists Immunosuppressants Metformin Production Topical Treatments Anticoagulants Viral Infections Anti-inflammatory Drugs COVID-19 Treatments Chronic Diseases Obesity NHS Beta-blockers Antiretrovirals Pain Relief Depo-Provera Obesity Management Tirzepatide Tylenol Gout Treatment Sleep Disorders Prescription Drugs Tacrolimus Weight Loss Drugs Aspirin Doliprane Diabetes Decongestants Drug Pricing Diabetes Treatments Nitisinone Drug Shortages Cardiac Medication

Lilly Files Orforglipron Obesity Pill With FDA After Trial Shows Weight-Loss Maintenance

The once-daily pill offers a needle-free alternative to injectables, with a U.S. decision anticipated in early 2026.

Babbel Names 2025’s Most Mispronounced Words, From Mamdani to the Louvre

Lundbeck Challenges Alkermes With Up to $23-Per-Share Offer for Avadel

Sam’s Club Joins Costco in Offering $499 Wegovy and Ozempic

AbbVie to Build $195 Million API Facility in North Chicago